A Study of Single and Multiple Subcutaneous or Intravenous Doses of ADX-001 in Healthy Adults to Assess Safety, Effects, and Immune Response

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a phase 1, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of subcutaneous and intravenous ADX-001 in healthy adult participants
Epistemonikos ID: a7ce9d66b1a920940b2b791d808c88a2767fc514
First added on: Oct 16, 2026